David Geffen School of Medicine at UCLA, Division of Digestive Diseases

Los Angeles, California 90092-7019

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed